I agree, these scientists/Doctors aren't cheap...who is paying, and in what form? With them just now finishing forming the board, may not hear anything about the product until Q4
I don't think the team he has built is unreasonable. Developing a health / medical product is not a simple thing. Mr. James has been smart with money and strategy so far. There are always significant research costs in a start up. As long as they remain focused and execute, it will be great for all.
He understands cash flow and that is key for a start up environment. Otherwise once you are out you are done. Unethical types will screw the shareholders sometimes while the ship is going down, but I really don't think this is the case here one bit.
I personally like the 'completed the group' so we know a) we have everyone needed to commercialize a product (ie Mr James has a product development plan and has resourced it appropriately) and b) we can expect things to move along now ie execute
Therefore no red flags at all. Just moving along. Just my $.02
cannabidiol supplements are not easy to formulate. they are going after pharma-grade quality. the cbd supplements you see on amazon run for 60 dollars for 4 ounces. and who know where it comes from. read dp's terratech interview with benzinga about the current state of cbd.
i am very glad that mj is so focused on cbd supplements, because i think it will be the next fish oil.
News 
Market Data 
Discover 
